| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Tamás F Freund | |
| István Katona | |||
| P2860 | cites work | Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 |
| Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 | ||
| Cannabinoid receptor localization in brain | Q24558751 | ||
| Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha | Q24564778 | ||
| A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 | ||
| Cannabinoids control spasticity and tremor in a multiple sclerosis model | Q28138564 | ||
| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
| Role of endogenous cannabinoids in synaptic signaling | Q28185075 | ||
| CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 | ||
| Leptin-regulated endocannabinoids are involved in maintaining food intake | Q28211969 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 | ||
| Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus | Q28268567 | ||
| Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus | Q28286042 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Homer: a protein that selectively binds metabotropic glutamate receptors | Q28305877 | ||
| Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 | ||
| Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice | Q28469322 | ||
| The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum | Q28587112 | ||
| Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors | Q28587334 | ||
| Phospholipase C isozymes selectively couple to specific neurotransmitter receptors | Q28593039 | ||
| The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation | Q28594581 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| The molecular logic of endocannabinoid signalling | Q29615356 | ||
| Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
| Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation | Q30478061 | ||
| Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program | Q31144410 | ||
| Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex | Q33293523 | ||
| Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors | Q44553567 | ||
| The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy | Q44572950 | ||
| A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. | Q44898084 | ||
| Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus | Q44927481 | ||
| Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 | ||
| A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. | Q45007590 | ||
| Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. | Q45138733 | ||
| Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. | Q45163158 | ||
| Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. | Q46624652 | ||
| Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. | Q46691853 | ||
| Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones | Q46716625 | ||
| Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. | Q46767737 | ||
| Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. | Q46793967 | ||
| Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
| Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release | Q48094449 | ||
| Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus | Q48103150 | ||
| Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. | Q48118951 | ||
| Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus | Q48173430 | ||
| Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. | Q48217036 | ||
| Visualization of 2-arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography | Q48297848 | ||
| Metabotropic suppression of excitation in murine autaptic hippocampal neurons | Q48367782 | ||
| Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. | Q48556515 | ||
| Coevolution between cannabinoid receptors and endocannabinoid ligands. | Q51913519 | ||
| CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus. | Q54579193 | ||
| CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons | Q60155175 | ||
| Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells | Q61479730 | ||
| Activation of the endocannabinoid system by organophosphorus nerve agents | Q34011342 | ||
| Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 | ||
| An endogenous cannabinoid (2-AG) is neuroprotective after brain injury | Q34093755 | ||
| Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis | Q34234907 | ||
| An endocannabinoid mechanism for stress-induced analgesia. | Q34428429 | ||
| Involvement of the endocannabinoid system in drug addiction | Q34495242 | ||
| Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand | Q34522513 | ||
| Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. | Q34548706 | ||
| Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection | Q34597537 | ||
| Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling | Q34650334 | ||
| Molecular composition of the endocannabinoid system at glutamatergic synapses. | Q35220762 | ||
| Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models | Q35545219 | ||
| Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors | Q35749646 | ||
| On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures | Q35903023 | ||
| Pharmacological actions of cannabinoids. | Q36441175 | ||
| Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors | Q36447081 | ||
| Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. | Q36452302 | ||
| Endocannabinoid-mediated synaptic plasticity in the CNS. | Q36507561 | ||
| Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin | Q36786835 | ||
| P2X7 receptors control 2-arachidonoylglycerol production by microglial cells | Q36854779 | ||
| A neuroscientist's guide to lipidomics. | Q36946556 | ||
| Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain | Q36997712 | ||
| Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses | Q37288785 | ||
| Presynaptic specificity of endocannabinoid signaling in the hippocampus | Q39750122 | ||
| Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus | Q39757955 | ||
| A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. | Q40116679 | ||
| Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. | Q40525710 | ||
| Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex | Q41905626 | ||
| The endocannabinoid system controls key epileptogenic circuits in the hippocampus | Q42065383 | ||
| CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action | Q42498502 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum | Q42523780 | ||
| Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit | Q43095188 | ||
| Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. | Q43570628 | ||
| Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals | Q43574291 | ||
| Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors | Q43715218 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity | Q44164051 | ||
| Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability | Q44437517 | ||
| Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. | Q44495434 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoids | Q10483908 |
| P304 | page(s) | 923-930 | |
| P577 | publication date | 2008-09-05 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Endocannabinoid signaling as a synaptic circuit breaker in neurological disease | |
| P478 | volume | 14 |
| Q37059166 | 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism |
| Q33730578 | A restricted population of CB1 cannabinoid receptors with neuroprotective activity |
| Q33839407 | A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy |
| Q33784846 | AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity |
| Q37716463 | Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model |
| Q48404416 | Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making. |
| Q40660673 | Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia |
| Q44574196 | Acute administration of THC impairs spatial but not associative memory function in zebrafish. |
| Q34384480 | Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia |
| Q36795697 | Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. |
| Q35076423 | Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder |
| Q92121452 | Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2 |
| Q35159081 | An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease. |
| Q43236175 | Anandamide extends platelets survival through CB(1)-dependent Akt signaling |
| Q54624346 | Anandamide inhibits oxidative phosphorylation in isolated liver mitochondria. |
| Q36225837 | Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors. |
| Q26750399 | Anticancer mechanisms of cannabinoids |
| Q35082356 | Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis |
| Q41271075 | Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study |
| Q35990574 | Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia |
| Q45185178 | Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia |
| Q33898545 | Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi |
| Q24621853 | Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling |
| Q36323518 | Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. |
| Q50068640 | Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells. |
| Q37128137 | CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses |
| Q47134613 | CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity |
| Q35668816 | CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling |
| Q28576747 | Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances |
| Q58775015 | Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain |
| Q36649684 | Cannabinoid Control of Learning and Memory through HCN Channels |
| Q55406347 | Cannabinoid Receptor Type 1 Expression in the Developing Avian Retina: Morphological and Functional Correlation With the Dopaminergic System. |
| Q90605726 | Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative? |
| Q55252194 | Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. |
| Q92097837 | Cannabinoid Signaling in Cancer |
| Q36267309 | Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats |
| Q34451442 | Cannabinoid modulation of drug reward and the implications of marijuana legalization |
| Q42508631 | Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress |
| Q36021048 | Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells |
| Q95319627 | Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia |
| Q37842745 | Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance |
| Q39359086 | Cannabinoid receptors CB1 and CB2 form functional heteromers in brain |
| Q36729800 | Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses |
| Q27336451 | Cannabinoids and Epilepsy. |
| Q34320242 | Cannabinoids and hallucinogens for headache |
| Q91934280 | Cannabinoids and the expanded endocannabinoid system in neurological disorders |
| Q35575211 | Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells. |
| Q38212376 | Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands |
| Q38605328 | Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development |
| Q38593127 | Cannabis and Endocannabinoid Signaling in Epilepsy |
| Q27024404 | Cannabis and psychosis: Neurobiology |
| Q90753196 | Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects |
| Q38767284 | Cellular and System Biology of Memory: Timing, Molecules, and Beyond |
| Q50658951 | Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. |
| Q38585032 | Changes in the adolescent brain and the pathophysiology of psychotic disorders |
| Q59136235 | Chemical fingerprinting of single glandular trichomes of Cannabis sativa by Coherent anti-Stokes Raman scattering (CARS) microscopy |
| Q34358086 | Chronic THC intake modifies fundamental cerebellar functions |
| Q36253945 | Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala |
| Q38735357 | Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana |
| Q90210535 | Comparative studies of endocannabinoid modulation of pain |
| Q36917918 | Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus |
| Q38503842 | Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. |
| Q88600929 | Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling |
| Q37093732 | Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks |
| Q36652237 | DAG-sensitive and Ca(2+) permeable TRPC6 channels are expressed in dentate granule cells and interneurons in the hippocampal formation. |
| Q30467190 | Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. |
| Q27303073 | Development of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthood |
| Q35080503 | Diacylglycerol lipase-alpha and -beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms |
| Q36990238 | Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats. |
| Q34556411 | Discovery of potent and reversible monoacylglycerol lipase inhibitors. |
| Q38874824 | Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors |
| Q30481732 | Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem |
| Q38162815 | Does exercise make migraines worse and tension type headaches better? |
| Q38056398 | Dynamic changes to the endocannabinoid system in models of chronic pain |
| Q27336497 | Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage |
| Q91004411 | Early endocannabinoid system activation attenuates behavioral impairments induced by initial impact but does not prevent epileptogenesis in lithium-pilocarpine status epilepticus model |
| Q35209678 | Effects of endocannabinoid system modulation on cognitive and emotional behavior |
| Q36918320 | Endocannabinoid Mediates Excitatory Synaptic Function of β-Neurexins. Commentary: β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling |
| Q36157617 | Endocannabinoid Signaling in Autism |
| Q52332832 | Endocannabinoid System and Migraine Pain: An Update. |
| Q33997873 | Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown |
| Q30473707 | Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects |
| Q83728202 | Endocannabinoid system protects against cryptogenic seizures |
| Q35193265 | Endocannabinoid tone versus constitutive activity of cannabinoid receptors |
| Q30492857 | Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities. |
| Q36389209 | Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. |
| Q38593139 | Endocannabinoids and Cancer. |
| Q34696352 | Endocannabinoids and diacylglycerol kinase activity |
| Q33565499 | Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons |
| Q37165496 | Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine |
| Q48085620 | Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity |
| Q36348362 | Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development |
| Q38262964 | Endocannabinoids, related compounds and their metabolic routes. |
| Q64913503 | Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system. |
| Q33624983 | Endogenous cannabinoid signaling at inhibitory interneurons. |
| Q36178329 | Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. |
| Q27692087 | Excitation-inhibition discoordination in rodent models of mental disorders |
| Q39550669 | Exercise-induced endocannabinoid signaling is modulated by intensity |
| Q91991227 | Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment |
| Q35069709 | Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma |
| Q36254721 | Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor |
| Q39610927 | Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor |
| Q48698997 | Gating the polarity of endocannabinoid-mediated synaptic plasticity by nitric oxide in the spinal locomotor network |
| Q30588621 | Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice |
| Q33991512 | Granule cells in the CA3 area. |
| Q37691232 | Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. |
| Q28083958 | Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning |
| Q35142914 | Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome. |
| Q42220568 | Impact of embedded endocannabinoids and their oxygenation by lipoxygenase on membrane properties |
| Q38697360 | Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility |
| Q37360865 | In vitro and in vivo evaluation of (11)C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors |
| Q28570135 | In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system |
| Q87594977 | In vitro properties of apheresis platelet during extended storage in plasma treated with anandamide |
| Q28283718 | Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction |
| Q98286403 | Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination |
| Q48635222 | Interictal psychosis following temporal lobe surgery: dentate gyrus pathology. |
| Q34247716 | Interneuron dysfunction in psychiatric disorders |
| Q34531690 | Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage |
| Q44697227 | Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain |
| Q35655078 | Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. |
| Q37295577 | Lipidomic analysis of endocannabinoid metabolism in biological samples. |
| Q41965347 | Localization of diacylglycerol lipase alpha and monoacylglycerol lipase during postnatal development of the rat retina |
| Q33814030 | Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus |
| Q30417555 | Long-term consequences of perinatal fatty acid amino hydrolase inhibition. |
| Q46328841 | Loss of Cannabinoid CB 1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility |
| Q28591248 | Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice |
| Q42478056 | Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. |
| Q99350059 | Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice |
| Q36297181 | Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility |
| Q37474536 | Measuring endocannabinoid hydrolysis: refining our tools and understanding |
| Q42146305 | Membrane environment and endocannabinoid signaling |
| Q50083472 | Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction |
| Q36514088 | Microdomains in forebrain spines: an ultrastructural perspective |
| Q26767489 | Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders |
| Q33636763 | Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. |
| Q27014154 | Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction |
| Q84197041 | Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus |
| Q37216017 | Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. |
| Q26998964 | Monoacylglycerol lipase - a target for drug development? |
| Q34270199 | Multiple functions of endocannabinoid signaling in the brain. |
| Q42714635 | N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities. |
| Q47652702 | Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential |
| Q37880502 | Neuroanatomical substrates involved in cannabinoid modulation of defensive responses. |
| Q38278954 | Neuroinflammation as a possible link between cannabinoids and addiction. |
| Q38684679 | Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation |
| Q47326858 | Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism. |
| Q34494301 | New insights on the role of the endocannabinoid system in the regulation of energy balance. |
| Q37688235 | Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment |
| Q37995375 | Off-target cannabinoid effects mediated by GPR55. |
| Q41502987 | Orchestrated activation of mGluR5 and CB1 promotes neuroprotection |
| Q39127073 | Pathophysiology of Migraine: A Disorder of Sensory Processing |
| Q50092568 | Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. |
| Q55333056 | Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. |
| Q52977311 | Pentylenetetrazol-induced seizure-like behavior and neural hyperactivity in the medicinal leech. |
| Q47648955 | Peripheral Endocannabinoids Associated with Energy Expenditure in Native Americans of Southwestern Heritage. |
| Q38801866 | Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine. |
| Q35694203 | Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons |
| Q38983579 | Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. |
| Q26752412 | Plasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the Synaptic Control in the Epileptic Brain |
| Q28252319 | Polymodal activation of the endocannabinoid system in the extended amygdala |
| Q34179419 | Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia |
| Q48971057 | Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex |
| Q48473239 | Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain |
| Q48735695 | Presynaptic calcium channel inhibition underlies CB₁ cannabinoid receptor-mediated suppression of GABA release. |
| Q38225535 | Presynaptic mechanisms of neuronal plasticity and their role in epilepsy |
| Q89125092 | Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop |
| Q36612284 | Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. |
| Q35000519 | Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons |
| Q47645331 | Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities |
| Q30495206 | Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis |
| Q48132194 | Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS. |
| Q42165768 | RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels. |
| Q36459472 | Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition |
| Q38128213 | Receptor trafficking and the regulation of synaptic plasticity by SUMO. |
| Q34072654 | Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy |
| Q36480259 | Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats |
| Q30415677 | Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. |
| Q34692930 | Review: Hippocampal sclerosis in epilepsy: a neuropathology review |
| Q92405873 | Role for Endocannabinoids in Spinal Manipulative Therapy Analgesia? |
| Q30502227 | Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging |
| Q48720514 | SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance |
| Q42935146 | Seizing an opportunity for the endocannabinoid system |
| Q30577728 | Seizure exacerbation in two patients with focal epilepsy following marijuana cessation |
| Q37399998 | Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model |
| Q39013000 | Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. |
| Q49072520 | Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa |
| Q30364687 | Social Stress and Psychosis Risk: Common Neurochemical Substrates? |
| Q30475004 | Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats |
| Q42497466 | State-dependent, bidirectional modulation of neural network activity by endocannabinoids. |
| Q36366738 | Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex |
| Q36132823 | Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. |
| Q47742909 | Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies? |
| Q39876164 | Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol |
| Q37553151 | Targeted lipidomics as a tool to investigate endocannabinoid function. |
| Q89861376 | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain |
| Q39744283 | Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice |
| Q42788578 | Temporal redistribution of inhibition over neuronal subcellular domains underlies state-dependent rhythmic change of excitability in the hippocampus |
| Q34812954 | Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. |
| Q36083021 | The Brain Prize 2011: From Microcircuit Organization to Constellations of Brain Rhythms |
| Q29306901 | The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway |
| Q41660878 | The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. |
| Q50226059 | The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. |
| Q41320259 | The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity |
| Q39420404 | The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development |
| Q47143679 | The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window |
| Q36176472 | The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors |
| Q37522883 | The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis |
| Q48318429 | The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels. |
| Q38669685 | The cannabinoid system and pain |
| Q55415383 | The current state and future perspectives of cannabinoids in cancer biology. |
| Q38220568 | The endocannabinoid system and appetite: relevance for food reward |
| Q34612917 | The endocannabinoid system and pain |
| Q37545714 | The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. |
| Q30471032 | The endocannabinoid system in anxiety, fear memory and habituation |
| Q48089129 | The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release. |
| Q35070299 | The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys |
| Q33525520 | The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas |
| Q89881678 | The habenular G-protein-coupled receptor 151 regulates synaptic plasticity and nicotine intake |
| Q34949720 | The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica |
| Q64284375 | The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPR and beyond |
| Q38606080 | The potential role of cannabinoids in epilepsy treatment |
| Q37913717 | The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. |
| Q24617322 | The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors |
| Q26859198 | The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission |
| Q37402927 | The therapeutic potential of novel cannabinoid receptors |
| Q84066889 | Towards the use of cannabinoids as antitumour agents |
| Q37381132 | Trajectory of adolescent cannabis use on addiction vulnerability |
| Q50933412 | Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. |
| Q42948746 | Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism |
| Q34571086 | Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells |
| Q28585288 | Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome |
| Q34582789 | Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus |
| Q47566341 | Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies. |
| Q35182513 | Visualization by high resolution immunoelectron microscopy of the transient receptor potential vanilloid-1 at inhibitory synapses of the mouse dentate gyrus |
| Q38428721 | Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy |
| Q26269814 | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling |
Search more.